Photo of Bruce Walcheck
Contact Expert

View Scopus Profile

Bruce Walcheck

1992 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Engineering iPSC-derived lymphocytes with recombinant Fc?? receptors for enhanced tumor cell targetingby therapeutic antibodies

Walcheck, B. & Wu, J.

Fate Therapeutics, Inc.

10/15/19 → 10/14/21

Project: Research project

    • HHMI Medical Research Fellows Program

    Walcheck, B.

    Howard Hughes Medical Institute

    8/13/19 → 8/13/20

    Project: Research project

    • Veterinary Summer Scholars in Comparative Medicine

    Walcheck, B.

    National Institutes of Health

    4/15/17 → 3/31/22

    Project: Research project

    • Blocking NK cell shedding of CD16ato increase cancer cel

    Walcheck, B., Kaufman, D. S. & Wu, J.

    National Institutes of Health

    1/1/16 → 12/31/20

    Project: Research project

    • Enhancing the function of CD16a in natural killer cells to improve tumor cell killing

    Walcheck, B.

    Howard Hughes Medical Institute

    8/13/18 → 8/12/19

    Project: Research project

    • Research Output

    A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

    Pomeroy, E. J., Hunzeker, J. T., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C. L., Yamamoto, K., Bendzick, L., Miller, J. S., Geller, M. A., Walcheck, B., Felices, M., Webber, B. R., Starr, T. K. & Moriarity, B. S., Jan 8 2020, In : Molecular Therapy. 28, 1

    Research output: Contribution to journal › Article

    • Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study

    Onyeaghala, G., Lane, J., Pankratz, N., Nelson, H. H., Thyagarajan, B., Walcheck, B., Anderson, K. E. & Prizment, A. E., Jun 2019, In : PloS one. 14, 6, e0217868.

    Research output: Contribution to journal › Article

    Open Access

    • iNK-CD64/16A cells: a promising approach for ADCC?

    Walcheck, B. & Wu, J., Dec 2 2019, In : Expert opinion on biological therapy. 19, 12, p. 1229-1232 4 p.

    Research output: Contribution to journal › Editorial

    Open Access

    • Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy

    Wu, J., Mishra, H. K. & Walcheck, B., Jun 2019, In : Journal of Leukocyte Biology. 105, 6, p. 1297-1303 7 p.

    Research output: Contribution to journal › Review article

    • 7 Scopus citations

    Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells

    Mishra, H. K., Pore, N., Michelotti, E. F. & Walcheck, B., Sep 1 2018, In : Cancer Immunology, Immunotherapy. 67, 9, p. 1407-1416 10 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations